Stock Price

AI firm YXT.com lands on a top innovation list with tech giants, but can its cutting-edge training solutions navigate a complex market and redefine work?

Ad-tech giant Teads reports massive revenue growth post-merger, but a $352M impairment and restructuring signal deep integration challenges.

Irish Continental Group posts a 10.4% revenue surge and record profits, driven by freight, but faces scrutiny over a sharp rise in debt and port issues.

German defense tech firm RENK Group reports a record €1.37B revenue, fueled by a 24% surge in its defense business amid global geopolitical tensions.

Strong 2025 results, aggressive share buybacks, and major growth projects define Athabasca's strategy. A deep dive into the company's future.

The VCT posts flat returns but rewards investors with a special dividend, announcing a new chair as it navigates a shifting regulatory landscape.

Once a failing firm, Aurelion Inc. bet its future on tokenized gold. The gamble paid off with a profitable quarter, but regulatory risks loom large.

LendingTree posts a record $319.7M Q4 driven by its insurance arm, yet an adjusted loss spooks investors. Can its AI-powered strategy win them back?

James River Group flips a $94M loss to a $30.1M profit, driven by strategic underwriting, cost cuts, and a pivotal move from Bermuda to Delaware.

Ag Growth International brings back its 23-year former CFO to the board, signaling a major push for operational excellence amid financial pressures.

NVIDIA invests billions in optics leader Coherent to secure the high-speed, US-made components needed to power the next generation of AI factories.

Fresh off a major clinical trial victory, Alumis Inc. heads to a key investor conference. What's next for its promising pipeline and soaring stock?

After a dramatic pivot and massive fundraising, Galecto will detail its new hematology pipeline at a key conference. Here’s what investors are watching.

Fidelis Insurance Group completes a $163M repurchase of all shares from founding investor CVC, a move set to boost shareholder value ahead of its rebrand.

Hain Celestial completes sale of Terra and Garden of Eatin' to pay down debt, betting its future on the high-margin tea, yogurt, and baby food markets.

Hopes for a new Huntington's gene therapy face a major delay as the FDA rejects uniQure's current data and calls for a more rigorous, complex study.

As Sri Lanka emerges from its economic crisis, a first-of-its-kind European-regulated fund provides a liquid, secure path to its undervalued assets.

As Prime Drink Group faces heavy losses, the appointment of water industry expert Germain Turpin as interim CEO signals a strategic pivot to its core assets.

The biotech firm's stock surged after announcing a massive share repurchase, a bold move balancing shareholder value with its high-stakes R&D pipeline.

A class action lawsuit alleges hospital operator Ardent Health misled investors by hiding financial risks, leading to a 33% stock price collapse.